Infrequent reinfection after successful treatment for hepatitis C virus infection in injection drug users.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 15546094.
- Also identified by PMC identifier 1510898.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We followed-up 18 injection drug users for a mean of 33.8 months (range, 4-55 months) after successful treatment for hepatitis C virus (HCV) infection. Fifteen (83%) of the patients remained HCV RNA-negative, 1 patient was not tested, and 2 patients had test results positive for HCV RNA. The estimated rate of reinfection as a result of injection drug use was 0-4.1 cases per 100 person-years (cumulative incidence, 0%-12.6% at 48 months after completion of treatment). Of 50 patients originally treated, 15 (30%) were HCV RNA-negative 3 years later.
Medical subject headings
- Hepatitis C
- Substance Abuse, Intravenous